Everyone talks about smarter drones. Almost no one talks about the invisible link that makes them usable. As global industries rethink security, latency, and supply chain risk, video transmission is becoming the real battleground—and LongLink is positioning itself right at the center of it.

Industrial R&D has long relied on trial-and-error—but what if that era is ending? Tricuss is introducing an AI “Co-Researcher” that can design experiments, analyze complex datasets, and generate research-grade insights in minutes. As industries from semiconductors to advanced materials face increasing complexity, this shift could redefine how innovation happens—and who leads it.

What if the best implant is the one that disappears? Expercy is challenging decades of orthopedic convention with absorbable biomaterials that don’t just support healing—they actively accelerate it, then dissolve when the job is done. From veterinary breakthroughs to future human applications, this is a new paradigm for surgery, recovery, and the role of medical devices in the body.

Organoids may be the future of medicine—but their production still looks like craftsmanship. PlasmonicTron is changing that. By turning fragile, manual biological workflows into automated, data-driven manufacturing systems, the company is redefining how living tissues are created at scale. The implications span drug discovery, personalized medicine, and beyond.

CephalonAI is compressing radiology diagnosis into minutes—while quietly reshaping the future of surgery, dementia care, and clinical decision-making.

Kidney stones are usually detected only after the pain begins—but that may be about to change. United Kaohsiung AI Medical Technology is redefining early detection with iStone, an AI system that analyzes routine urine and blood tests to predict risk before symptoms appear. It’s a quiet but powerful shift from reactive care to preventive intelligence—and it’s coming to Silicon Valley.

What if machines could smell? Enosim is turning odor into data with its AI-powered Sextant platform—unlocking new frontiers in healthcare diagnostics, industrial safety, robotics, and beyond. From breath-based disease detection to real-time quality control, this is the missing sensory layer in the age of intelligent systems. Meet the team redefining how the world senses reality at the Taiwan Innovation Spotlight in Silicon Valley.

What if the most powerful new therapy in medicine wasn’t complex—but invisible? HOHO Biotech is betting on molecular hydrogen to reshape how we approach inflammation, aging, and chronic disease—challenging everything we thought we knew about treatment.

What if glass could think? Seeing Display is turning everyday windows into intelligent systems—adaptive, energy-efficient, and programmable. With its breakthrough Memory Liquid Crystal technology, buildings may soon reduce energy costs, enhance privacy, and redefine how architecture interacts with people.

What if the future of cancer drug discovery no longer depends on animal testing? Fluidiconic Biotechnology is building a new paradigm with its tumor-on-a-chip platform—recreating human tumor environments in vitro and accelerating how therapies are tested, validated, and brought to market. As pharma, biotech, and AI-driven drug discovery collide, this breakthrough could redefine the entire pipeline.

What if the real bottleneck in drug discovery isn’t intelligence—but execution? Coherence is reimagining the laboratory itself as a programmable system, where AI doesn’t just predict outcomes but actively runs experiments, learns from results, and accelerates discovery at machine speed. As biology becomes increasingly digitized, Coherence offers a glimpse into a future where scientific breakthroughs are no longer limited by human throughput—and where the pace of innovation co

What if healing didn’t rely on synthetic implants, but on materials the body already understands? FMG Biomed is pushing a new frontier with collagen-based biomaterials that guide the body to regenerate itself—reshaping wound care, bone repair, and the future of regenerative medicine.

While the EV industry chases bigger batteries and longer range, a quieter revolution is taking place beneath the surface. Purism EV is challenging the status quo with smart power distribution modules that optimize how energy flows across the vehicle—unlocking efficiency, reducing costs, and redefining what performance really means in the electric era.

As AI hardware pushes the limits of physics, the real bottleneck is no longer compute—it’s interference and heat. Black Solution Nanotech is tackling this invisible battlefield with graphene metamaterials that redefine how chips perform, scale, and survive in next-generation systems.

Silicon built the modern world—but it may not power the next one. As demand surges for high-efficiency systems in electric vehicles, AI data centers, and energy infrastructure, silicon carbide is emerging as the material rewriting the rules. At the center of this shift is Gechi Compound Semiconductor, a company tackling one of the hardest problems in tech: growing and scaling high-quality SiC crystals. This is not just a story about semiconductors—it’s about who controls the

What if the future of medicine isn’t about stronger drugs—but smarter delivery? MegaPro by AP Biosciences is redefining how we diagnose and treat disease through nanotechnology, from Phase III MRI contrast agents to precision-targeted cancer therapies. This is where medicine becomes engineered.

For decades, cycling has been built around a simple assumption: the circle is optimal. Hao Juen challenges that belief with a radically different approach—customized non-circular chainrings engineered from real pedaling data to reduce power loss and enhance efficiency. The result is a subtle yet powerful upgrade that could redefine performance not just for cyclists, but for how machines adapt to human motion.

IVF success has long been capped at around 40%, leaving patients with uncertainty and repeated cycles. AB DigiHealth is changing that equation by shifting embryo selection from visual assessment to AI-driven genomic analysis—unlocking deeper insights directly from NGS data. The result is a potential leap in implantation success and a new frontier for reproductive medicine.

What if the future of critical care could be swallowed? DotSpace’s PressureDOT is redefining how we monitor life-threatening conditions—turning invasive procedures into seamless, continuous insights from within the body.

What if the future of optics had nothing to do with glass? MetaRosetta is pioneering metalens technology—ultra-thin, nanostructured surfaces that could replace traditional lenses across machine vision, infrared sensing, and thermal imaging. As optics converges with semiconductor manufacturing, this shift may redefine how machines see—and who controls that capability.